Lucid Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary
I'm PortAI, I can summarize articles.
Lucid Diagnostics Inc reported a quarterly adjusted loss of 8 cents per share for the quarter ended June 30, an improvement from a loss of 23 cents per share a year ago. Revenue increased by 19.2% to $1.16 million, slightly above analyst expectations. The company incurred a total loss of $7.89 million this quarter. Despite a 13.3% drop in shares this quarter, they have gained 21.8% year-to-date. Analysts maintain a "buy" rating, with a median 12-month price target of $3.00, indicating a potential upside of 66.8% from the last closing price of $1.00.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments